- ►annals.org A Qaseem, V Snow, TD Denberg, MA Forciea … - Annals of Internal Medicine, 2008 - Am Coll Physicians Methods: Published literature on this topic was identified by using MEDLINE,
EMBASE, PsychLit, the Cochrane Central Register of Controlled Trials, and
International Pharmaceutical Abstracts from 1980 to April 2007. Searches ... Cited by 15 - Related articles - All 5 versions
GS Malhi, D Adams, R Porter, A Wignall, L … - Acta Psychiatr Scand, 2009 - d.yimg.com GS Malhi1,2,3, D. Adams1,2, R. Porter4, A. Wignall5, L. Lampe1,2,3, N.
OÕConnor3,6, M. Paton2, LA Newton2, G. Walter3,5, A. Taylor2, M. Berk7,8,9, RT
Mulder4 1CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, ... Cited by 6 - Related articles - View as HTML - All 7 versions
V Patel, G Simon, N Chowdhary, S Kaaya, R …, 2009 - pubmedcentral.nih.gov Copyright Patel et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original ... Cited by 4 - Related articles - All 5 versions
G Gartlehner, BN Gaynes, RA Hansen, KN … - The Lancet, 2009 - Elsevier In their multiple-treatment meta-analysis, Andrea Cipriani and colleagues 1
conclude that clinically important differences favour escitalopram and
sertraline over other second-generation antidepressants. We published a ... Cited by 2 - Related articles - All 31 versions
F Benedetti, E Smeraldi - Current Pharmaceutical Design, 2009 - ingentaconnect.com Abstract: Despite confirmed evidences about some neurochemical effects of
antidepressant treatments, there is still a high level of uncertainty about
which biological changes are needed to recover from a major depressive ... Cited by 1 - Related articles - All 3 versions
- ►psychiatryonline.org A Little, RA Hansen, G Gartlehner, C Gray - Psychiatric Services, 2009 - Am Psychiatric Assoc ). Dr. Hansen is with the Division of Pharmaceutical Outcomes, Eshelman School
of Pharmacy, University of North Carolina at Chapel Hill. Dr. Gartlehner is with
the Department of Evidence-Based Medicine and Clinical Epidemiology, Danube ... Cited by 1
G Gartlehner, BN Gaynes - British Medical Journal, 2009 - ebmh.bmj.com Clinicians prescribing SGAs face a multitude of drug choices and are the target
of extensive marketing campaigns by the pharmaceutical industry. In 2007, three
of the 20 top selling drugs in the USA were antidepressants with annual ... Cited by 1 - Related articles
JPA Ioannidis - The Lancet, 2009 - Elsevier Assessing the effectiveness of antidepressants on the basis of how they perform
against placebo, each other, or both, yields discrepant results (table).
Escitalopram and sertraline, the winners according to Cipriani and ... Cited by 1 - Related articles - All 21 versions
AC Tsai - The Lancet, 2009 - Elsevier Subtle exposure to small pharmaceutical brand items has been shown to have an
unconscious influence on branding preferences among medical students. 3 This
evidence cannot be ignored as a potential side-effect of the exposure, ... Cited by 1 - Related articles - All 16 versions
A Cipriani, JR Geddes, TA Furukawa, G … - The Lancet, 2009 - Elsevier The effect of financial conflict of interest in biomedical research (sponsorship
bias and publication bias) is now well established. 1 Our 12 preparatory
systematic reviews were as systematic as possible (in terms of both the ... Cited by 1 - Related articles - All 31 versions
